No valuation for STAQ Pharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($95.8M) and the funding record below are the closest available signals.
- ·The complete investor list: 13 names
- ·Watch STAQ Pharma: the Monday email on marks, rounds and moves
STAQ Pharma funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2024 | Early Stage VC | $11.4M | ▮ | ▮ |
| Apr 2023 | Early Stage VC | $10.1M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $30.3M | ▮ | ▮ |
| Apr 2019 | Early Stage VC | $9.0M | ▮ | ▮ |
Membership and data by Private Market View
How much has STAQ Pharma raised?
STAQ Pharma has raised $95.8 million across 4 recorded rounds since 2019. The largest was a $9 million early-stage round in Apr 2019; the most recent was an $11.4 million early-stage round in Sep 2024.
STAQ Pharma has filed 9 Form Ds with the SEC since 2019, most recently in Sep 2024 ($11.4 million sold to 8 investors).
How STAQ Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For STAQ Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about STAQ Pharma
- How much has STAQ Pharma raised?
- STAQ Pharma has raised $95.8M in total funding across 4 recorded rounds.
- When did STAQ Pharma last raise?
- STAQ Pharma last raised in Sep 2024 (Early Stage VC), raising $11.4M.